SCHEMBL8667916

SCHEMBL8667916

Nc1ccc([CH]Cc2ccc(N)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ GFER P55789 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ LOXL2 Q9Y4K0 1/20 0.46
▸ APP P05067 2/20 0.42
▸ CYP19A1 P11511 6/20 0.41
▸ MAOB P27338 5/20 0.41
▸ MAOA P21397 3/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ CYP17A1 P05093 1/20 0.34
▸ CYP11B1 P15538 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5852576 0.89 MAOB (0.52) ALDH1A1CYP3A4TDP1GFERTSHR
SCHEMBL8366101 0.89 MAOB (0.52) ALDH1A1CYP3A4TDP1GFERTSHR
SCHEMBL7142638 0.82 GAA (0.42) ALDH1A1CYP3A4TDP1TSHR
SCHEMBL8669516 0.77 CYP2A6 (0.46) ALDH1A1KMT2AMAPTRAB9A
SCHEMBL3222357 0.76 APP (0.50) ALDH1A1CYP3A4TDP1GFERTSHR
SCHEMBL8668773 0.75 ABAT (0.50) ALDH1A1CYP3A4TDP1APPMAOB
SCHEMBL8670278 0.75 PRSS1 (0.43) TSHRCYP11B1CYP11B2
SCHEMBL9588199 0.75 HSD17B10 (0.50) ALDH1A1MAOBMAPTNPC1RAB9A
SCHEMBL8364378 0.75 TRPA1 (0.45) LOXL2MAOBMAOAKMT2ANPC1
SCHEMBL5056468 0.75 CYP2A6 (0.50) TDP1MAOBMAOAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 — — US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 — — US disclosed
EP-0686151-A1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-12-13 — — EP disclosed
Send feedback